Opinion: Unethical Ethics Monitoring

Anti-plagiarism service iThenticate breached ethical boundaries in its design and interpretation of a survey of the top ethical concerns among scientific journal editors.

Written byDavid C. Beebe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, BRADY WITHERSThis winter, I received a request to participate in a survey to identify the “top ethical and industry concerns of those at the helm of scholarly journals.” The survey was sponsored by iParadigms LLC, the company that sells iThenticate, a service to identify plagiarism in scientific publications. Since I am editor-in-chief of Investigative Ophthalmology and Visual Science, a journal that uses iThenticate software to check for plagiarism, I considered taking the survey. Reading through the questions, however, I felt that the survey was “rigged”—designed in such a way that plagiarism would undoubtedly come out as the top concern—so I declined to submit my responses.

In April, I listened to an iThenticate-sponsored webinar, moderated by Jason Chu of iParadigms’ website plagiarism.org, in which invited speakers Virginia Barbour, council chair at the Committee on Publication Ethics (COPE), and David Moher, editor-in-chief at the journal Systematic Reviews, discussed the results of the survey. Not surprisingly, the top concern—cited by 82 percent of the editors and editorial staff who responded to the survey—was “plagiarism and misconduct.” However, throughout the webinar and in the summary published online at the iThenticate website, this choice was referred to only as “plagiarism.” Data falsification or manipulation, which I consider to be much more serious transgressions than plagiarism, were not highlighted by iThenticate as major concerns, despite clearly falling under the umbrella of research misconduct. This confirmed my ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies